Skip to main content

Table 4 Restimulation and response

From: Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Patient Increase of IFN-γ secreting T-lymphocytes HAMA (ng/ml) Chemotherapy after trAb therapy Survival after trAb therapy (months)
A + 801 - 1
B + 230 + 21
C - 30512 + 31
D - n.d. - 4
E + 7870 + 7
F - 50730 + 12
G + 2540 + 15
H - 400 + 8
I + n.d. - 7
  1. Increase of IFN-γ secreting T-lymphocytes compared to baseline values before therapy. HAMA = human anti-mouse antibody reaction (values measured 4 weeks after trAb therapy).